Evergreen Farm & Garden acquired by Green Tractors

Apr 04, 2022

Acquisition takes effect on April 11, 2022.

As of April 11, 2022, the Orono, Ontario-located Evergreen Farm & Garden will be joining the Green Tractors Inc. dealer network.

Green Tractors is a full-service John Deere dealership network, now with nine locations across southern, central and eastern Ontario. It offers a full lineup of John Deere agricultural, commercial, worksite, residential, and golf & turf equipment, as well as many other fine equipment lines to meet its clients’ needs.
Evergreen Farm & Garden has been serving customers since 1989 in the Durham region—providing ag, commercial and residential consumer products and services.

For Green Tractors, the Orono-located shop will round out the company’s presence in the Durham area, and will continue to offer all John Deere products as well as welcoming the Compact Construction Equipment line.

The combination of Green Tractors’ strong presence in the agricultural, commercial and municipal markets along with Evergreen’s rich community commitment and experience, will, the company hopes, provide better support through increased product and service specialization and larger parts and equipment inventories.

More information on Green Tractors available at https://www.greentractors.ca.

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.